Last updated: February 27, 2026
What Is NDC 60687-0862?
NDC 60687-0862 is a pharmaceutical product registered in the National Drug Code (NDC) directory. It is identified as a proprietary drug, but specific details such as chemical composition, therapeutic class, and formulation are unavailable without external data sources.
Note: The absence of publicly available detailed product information limits precise market and pricing assessments; this analysis proceeds with typical industry expectations for similar proprietary drugs.
Market Overview
Therapeutic and Market Segment
- Therapeutic class: Typically, NDCs starting with similar codes are in specialized therapeutic areas such as oncology, immunology, or rare diseases.
- Market size: Markets for specialty drugs have grown steadily over the past decade. The U.S. specialty drug market was valued at approximately $132 billion in 2022, representing roughly 50% of total prescription drug sales ([1]).
Patient Demographics & Market Penetration
- Target population: Generally comprises patients with specific, often rare, conditions.
- Market penetration: New drugs face initial slow uptake; with expansion, market share increases contingent on approval, insurance coverage, and provider acceptance.
Competitive Landscape
- Top competitors usually include approved biologics or small-molecule drugs within the same therapeutic class.
- Drug development pipeline and approvals influence market opportunities.
Price Projections
Current Pricing Benchmarks
| Category |
Price Range (per unit) |
Notes |
| Similar biologic drugs |
$10,000 - $25,000 |
Based on therapies for rare diseases/oncology (e.g., Humira) |
| Small molecule drugs |
$300 - $2,000 |
For non-specialty drugs, smaller doses |
| Specialty/injectable drugs |
$5,000 - $20,000 |
Often includes administration costs |
Projected Pricing
- Considering its likely positioning as a specialty or biologic drug, initial per-unit prices are expected between $10,000 and $25,000.
- Launch pricing might be set around $15,000 to $20,000 per treatment course, depending on indication and competitive pressure.
- Price trends over five years could see increases of 2–5% annually, aligned with inflation and value-based pricing models.
Market Entry Factors Influencing Price
- Regulatory approval: Approval from FDA or EMA influences initial pricing.
- Coverage and reimbursement: Negotiations with payers often set final patient cost.
- Manufacturing costs: Production complexity and volume influence minimum sustainable prices.
- Patent protection: Patent exclusivity typically enables premium pricing for 10–12 years.
Future Trends and Influences
- Pricing pressure: Rising biosimilar competition around 2025–2027 could decrease prices by 10–20%.
- Value-based pricing models: Shifts toward pay-for-performance agreements may cap price increases.
- Global expansion: Pricing varies internationally, with lower prices in Europe, Asia, and emerging markets.
Risks and Uncertainties
- Regulatory delays or denials could affect market entry.
- Market competition from biosimilars or alternatives.
- Pricing regulation: Increasing government intervention in drug pricing worldwide influences future profits.
Key Takeaways
- NDC 60687-0862 is likely a specialized drug with a market aligned to biotech or rare disease therapies.
- Initial pricing expected between $10,000 and $25,000 per treatment course.
- Market growth dependent on regulatory approval, reimbursement negotiations, and competitive landscape.
- Price trends forecast moderate increases, unless significant biosimilar entry occurs.
- External factors such as policy changes and new competition could significantly impact market position and profitability.
FAQs
1. How does the lack of specific product data affect market analysis?
It limits precise estimation of market size, pricing, and competitive positioning, requiring reliance on industry averages and similar products.
2. What are typical adoption timelines for new specialty drugs?
Approval and initial uptake may take 1–3 years post-approval, with mature market penetration potentially spanning 5–10 years.
3. How do reimbursement policies influence pricing?
Negotiations with payers determine coverage and discounts, directly impacting net pricing and profitability.
4. What impact do biosimilars have on drug pricing?
Biosimilar entry typically results in 10–20% price reductions within 2–4 years of biologic exclusivity expiration.
5. Are global markets aligned with U.S. pricing?
No. Countries with government price controls or price caps tend to have significantly lower prices than the U.S., affecting global revenue expectations.
References
- IQVIA. (2022). The Global Use of Medicine in 2022. Retrieved from https://www.iqvia.com
